Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (27)

2024

  1. Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

    Scientific Reports, Vol. 14, Núm. 1

  2. Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation

    Frontiers in Immunology, Vol. 15

  3. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

    Liver International, Vol. 44, Núm. 2, pp. 279-285

2022

  1. Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study

    Infection, Vol. 50, Núm. 2, pp. 371-380

2021

  1. Covid-19 clinical profile in latin american migrants living in spain: Does the geographical origin matter?

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  2. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort

    Transplant International, Vol. 34, Núm. 10, pp. 1908-1913

  3. The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19

    Therapeutic Advances in Gastroenterology, Vol. 14

2020

  1. Proceedings of the 25th annual congress of the international liver transplantation society

    Transplantation, Vol. 104, Núm. 8, pp. 1560-1565

  2. Recipient Age for Liver Transplantation: Should It Be Limited? A Propensity Score Matching Analysis of a Large European Series

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1442-1449

2017

  1. Sofosbuvir and daclatasvir in mono-and HIV-coinfected patients with recurrent hepatitis C After liver transplant

    Annals of Hepatology, Vol. 16, Núm. 1, pp. 86-93

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  2. Impact of cytomegalovirus infection on severe hepatitis c recurrence in patients undergoing liver transplantation

    Transplantation, Vol. 100, Núm. 3, pp. 593-599

  3. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

    Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 12, pp. 1319-1329

2015

  1. Doubtful role of IL28B polymorphism in occult Hepatitis B infection

    Intervirology, Vol. 58, Núm. 3, pp. 160-165

2014

  1. Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection

    PLoS ONE, Vol. 9, Núm. 7

  2. Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: A cohort study

    Liver Transplantation, Vol. 20, Núm. 7, pp. 856-863

2012

  1. IL28B genetic variation and hepatitis C virus-specific CD4+ T-cell responses in anti-HCV-positive blood donors

    Journal of Viral Hepatitis, Vol. 19, Núm. 12, pp. 867-871

  2. Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

    Bone Marrow Transplantation, Vol. 47, Núm. 10, pp. 1343-1349

  3. Reversal of nonstructural protein 3-specific CD4 + T cell dysfunction in patients with persistent hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 19, Núm. 4, pp. 283-294

  4. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature

    Liver Transplantation, Vol. 18, Núm. 2, pp. 201-205